AU1014695A
(en)
*
|
1994-02-17 |
1995-08-24 |
Collagen Corporation |
Collagen-synthetic polymer conjugates having controlled fiber size distributions
|
EP0713707A1
(en)
*
|
1994-11-23 |
1996-05-29 |
Collagen Corporation |
In situ crosslinkable, injectable collagen composition for tissue augmention
|
US8603511B2
(en)
|
1996-08-27 |
2013-12-10 |
Baxter International, Inc. |
Fragmented polymeric compositions and methods for their use
|
US6706690B2
(en)
|
1999-06-10 |
2004-03-16 |
Baxter Healthcare Corporation |
Hemoactive compositions and methods for their manufacture and use
|
US8303981B2
(en)
|
1996-08-27 |
2012-11-06 |
Baxter International Inc. |
Fragmented polymeric compositions and methods for their use
|
US7871637B2
(en)
|
1996-08-27 |
2011-01-18 |
Baxter International Inc. |
Dry hemostatic compositions and methods for their preparation
|
US7435425B2
(en)
*
|
2001-07-17 |
2008-10-14 |
Baxter International, Inc. |
Dry hemostatic compositions and methods for their preparation
|
US6066325A
(en)
|
1996-08-27 |
2000-05-23 |
Fusion Medical Technologies, Inc. |
Fragmented polymeric compositions and methods for their use
|
US6063061A
(en)
*
|
1996-08-27 |
2000-05-16 |
Fusion Medical Technologies, Inc. |
Fragmented polymeric compositions and methods for their use
|
US7320962B2
(en)
|
1996-08-27 |
2008-01-22 |
Baxter International Inc. |
Hemoactive compositions and methods for their manufacture and use
|
GB2345638A
(en)
*
|
1998-09-11 |
2000-07-19 |
Tissue Science Lab Limited |
Injectable collagen compositions
|
US6264987B1
(en)
|
2000-05-19 |
2001-07-24 |
Alkermes Controlled Therapeutics Inc. Ii |
Method for preparing microparticles having a selected polymer molecular weight
|
US6495164B1
(en)
*
|
2000-05-25 |
2002-12-17 |
Alkermes Controlled Therapeutics, Inc. I |
Preparation of injectable suspensions having improved injectability
|
US6824822B2
(en)
*
|
2001-08-31 |
2004-11-30 |
Alkermes Controlled Therapeutics Inc. Ii |
Residual solvent extraction method and microparticles produced thereby
|
US6471995B1
(en)
|
2000-09-27 |
2002-10-29 |
Alkermes Controlled Therapeutics, Inc. Ii |
Apparatus and method for preparing microparticles using liquid-liquid extraction
|
US20020114843A1
(en)
*
|
2000-12-27 |
2002-08-22 |
Ramstack J. Michael |
Preparation of microparticles having improved flowability
|
US9080146B2
(en)
|
2001-01-11 |
2015-07-14 |
Celonova Biosciences, Inc. |
Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with a micro-structured surface
|
US7105182B2
(en)
*
|
2001-07-25 |
2006-09-12 |
Szymaitis Dennis W |
Periodontal regeneration composition and method of using same
|
US20040028676A1
(en)
*
|
2002-08-06 |
2004-02-12 |
Klein Dean A. |
Swallowing system tissue modifier
|
CN1310946C
(zh)
*
|
2002-12-18 |
2007-04-18 |
和康生物科技股份有限公司 |
注射性胶原蛋白的制备方法及其产品
|
FR2850282B1
(fr)
|
2003-01-27 |
2007-04-06 |
Jerome Asius |
Implant injectable a base de ceramique pour le comblement de rides, depressions cutanees et cicatrices, et sa preparation
|
FR2861734B1
(fr)
|
2003-04-10 |
2006-04-14 |
Corneal Ind |
Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
|
US8834864B2
(en)
*
|
2003-06-05 |
2014-09-16 |
Baxter International Inc. |
Methods for repairing and regenerating human dura mater
|
US7927626B2
(en)
|
2003-08-07 |
2011-04-19 |
Ethicon, Inc. |
Process of making flowable hemostatic compositions and devices containing such compositions
|
US20090148527A1
(en)
*
|
2007-12-07 |
2009-06-11 |
Robinson Michael R |
Intraocular formulation
|
CN1968700A
(zh)
*
|
2004-04-15 |
2007-05-23 |
阿尔克姆斯有限公司 |
聚合物基的持续释放装置
|
JP4694163B2
(ja)
*
|
2004-07-26 |
2011-06-08 |
株式会社ジーシー |
生体吸収性顆粒状多孔質骨補填材の製造方法
|
US20210299056A9
(en)
|
2004-10-25 |
2021-09-30 |
Varian Medical Systems, Inc. |
Color-Coded Polymeric Particles of Predetermined Size for Therapeutic and/or Diagnostic Applications and Related Methods
|
US9107850B2
(en)
|
2004-10-25 |
2015-08-18 |
Celonova Biosciences, Inc. |
Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
|
AU2005298344B2
(en)
|
2004-10-25 |
2011-02-10 |
Varian Medical Systems, Inc. |
Loadable polyphosphazene-comprising particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
|
US9114162B2
(en)
|
2004-10-25 |
2015-08-25 |
Celonova Biosciences, Inc. |
Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same
|
US20060100138A1
(en)
*
|
2004-11-10 |
2006-05-11 |
Olsen David R |
Implantable collagen compositions
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
WO2007137839A2
(en)
*
|
2006-05-31 |
2007-12-06 |
Baxter International Inc. |
Method for directed cell in-growth and controlled tissue regeneration in spinal surgery
|
TWI436793B
(zh)
|
2006-08-02 |
2014-05-11 |
Baxter Int |
快速作用之乾密封膠及其使用和製造方法
|
KR101200728B1
(ko)
|
2006-08-09 |
2012-11-13 |
인타르시아 세라퓨틱스 인코포레이티드 |
삼투성 전달 시스템 및 피스톤 조립체
|
WO2008118712A1
(en)
*
|
2007-03-22 |
2008-10-02 |
Alkermes, Inc. |
Coacervation process
|
AU2008244523B2
(en)
|
2007-04-23 |
2012-02-16 |
Intarcia Therapeutics, Inc. |
Suspension formulations of insulinotropic peptides and uses thereof
|
EP2152743A2
(en)
*
|
2007-05-23 |
2010-02-17 |
Allergan, Inc. |
Cross-linked collagen and uses thereof
|
US20080317865A1
(en)
*
|
2007-06-20 |
2008-12-25 |
Alkermes, Inc. |
Quench liquids and washing systems for production of microparticles
|
US8697044B2
(en)
*
|
2007-10-09 |
2014-04-15 |
Allergan, Inc. |
Crossed-linked hyaluronic acid and collagen and uses thereof
|
EP2214734B1
(en)
|
2007-10-30 |
2017-12-13 |
Baxter International Inc. |
Use of a regenerative biofunctional collagen biomatrix for treating visceral or parietal defects
|
SI2818184T1
(sl)
|
2007-11-16 |
2019-03-29 |
Aclaris Therapeutics, Inc. |
Sestava in postopki za zdravljenje purpure
|
US20090143348A1
(en)
*
|
2007-11-30 |
2009-06-04 |
Ahmet Tezel |
Polysaccharide gel compositions and methods for sustained delivery of drugs
|
US8394784B2
(en)
|
2007-11-30 |
2013-03-12 |
Allergan, Inc. |
Polysaccharide gel formulation having multi-stage bioactive agent delivery
|
US8394782B2
(en)
*
|
2007-11-30 |
2013-03-12 |
Allergan, Inc. |
Polysaccharide gel formulation having increased longevity
|
US8167787B2
(en)
|
2008-01-03 |
2012-05-01 |
Revent Medical, Inc. |
Partially erodable systems for treatment of obstructive sleep apnea
|
EP2240155B1
(en)
|
2008-02-13 |
2012-06-06 |
Intarcia Therapeutics, Inc |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
JP5569398B2
(ja)
|
2008-02-29 |
2014-08-13 |
フェッローサン メディカル ディバイス エー/エス |
止血および/または創傷治癒を促進するための装置
|
US9439801B2
(en)
|
2012-06-29 |
2016-09-13 |
Revent Medical, Inc. |
Systems and methods for treatment of sleep apnea
|
JP5834337B2
(ja)
*
|
2008-05-12 |
2015-12-16 |
レベント メディカル インコーポレイテッド |
閉塞性睡眠時無呼吸の治療のための部分的侵食性システム
|
US8776799B2
(en)
|
2010-03-19 |
2014-07-15 |
Revent Medical, Inc. |
Systems and methods for treatment of sleep apnea
|
US8733363B2
(en)
*
|
2010-03-19 |
2014-05-27 |
Revent Medical, Inc. |
Systems and methods for treatment of sleep apnea
|
ES2668398T3
(es)
*
|
2008-07-02 |
2018-05-17 |
Allergan, Inc. |
Composiciones y procedimientos para el relleno y la regeneración de tejidos
|
US8357795B2
(en)
|
2008-08-04 |
2013-01-22 |
Allergan, Inc. |
Hyaluronic acid-based gels including lidocaine
|
AU2009288118B2
(en)
|
2008-09-02 |
2014-12-11 |
Allergan, Inc. |
Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
|
US9039783B2
(en)
|
2009-05-18 |
2015-05-26 |
Baxter International, Inc. |
Method for the improvement of mesh implant biocompatibility
|
KR101699992B1
(ko)
|
2009-06-16 |
2017-01-26 |
백스터 인터내셔널 인코포레이티드 |
지혈용 스펀지
|
SI2462246T1
(en)
|
2009-09-28 |
2018-01-31 |
Intarcia Therapeutics, Inc. |
Fast-setting and / or cessation of substantially unchanged delivery of the product
|
AU2010339045B2
(en)
|
2009-12-16 |
2014-06-05 |
Baxter Healthcare S.A. |
Hemostatic sponge
|
US9114188B2
(en)
|
2010-01-13 |
2015-08-25 |
Allergan, Industrie, S.A.S. |
Stable hydrogel compositions including additives
|
US20110172180A1
(en)
|
2010-01-13 |
2011-07-14 |
Allergan Industrie. Sas |
Heat stable hyaluronic acid compositions for dermatological use
|
US20110171286A1
(en)
*
|
2010-01-13 |
2011-07-14 |
Allergan, Inc. |
Hyaluronic acid compositions for dermatological use
|
US20110171311A1
(en)
*
|
2010-01-13 |
2011-07-14 |
Allergan Industrie, Sas |
Stable hydrogel compositions including additives
|
NZ602405A
(en)
|
2010-03-12 |
2014-12-24 |
Allergan Ind Sas |
A fluid composition comprising a hyaluronan polymer and mannitol for improving skin conditions
|
PT2550027T
(pt)
|
2010-03-22 |
2016-08-12 |
Allergan Inc |
Hidrogéis reticulados à base de polissacáridos e proteínopolissacáridos para aumento dos tecidos moles
|
US9987114B2
(en)
|
2010-03-24 |
2018-06-05 |
Covidien Lp |
Combination three-dimensional surgical implant
|
SA111320355B1
(ar)
|
2010-04-07 |
2015-01-08 |
Baxter Heathcare S A |
إسفنجة لايقاف النزف
|
WO2011146930A2
(en)
|
2010-05-21 |
2011-11-24 |
Revent Medical, Inc. |
Systems and methods for treatment of sleep apnea
|
CN103037847B
(zh)
|
2010-06-01 |
2016-01-20 |
巴克斯特国际公司 |
用于制备干燥、稳定的止血组合物的方法
|
US8940335B2
(en)
|
2010-06-01 |
2015-01-27 |
Baxter International Inc. |
Process for making dry and stable hemostatic compositions
|
JP6289096B2
(ja)
|
2010-06-01 |
2018-03-07 |
バクスター・インターナショナル・インコーポレイテッドBaxter International Incorp0Rated |
乾燥した安定な止血組成物を作製するためのプロセス
|
WO2012018545A2
(en)
|
2010-07-26 |
2012-02-09 |
Revent Medical, Inc. |
Systems and methods for treatment of sleep apnea
|
US8697057B2
(en)
|
2010-08-19 |
2014-04-15 |
Allergan, Inc. |
Compositions and soft tissue replacement methods
|
US9005605B2
(en)
|
2010-08-19 |
2015-04-14 |
Allergan, Inc. |
Compositions and soft tissue replacement methods
|
US8889123B2
(en)
|
2010-08-19 |
2014-11-18 |
Allergan, Inc. |
Compositions and soft tissue replacement methods
|
US8883139B2
(en)
|
2010-08-19 |
2014-11-11 |
Allergan Inc. |
Compositions and soft tissue replacement methods
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
US9447169B2
(en)
|
2011-03-04 |
2016-09-20 |
Orthovita, Inc. |
Flowable collagen-based hemostat and methods of use
|
US9408797B2
(en)
|
2011-06-03 |
2016-08-09 |
Allergan, Inc. |
Dermal filler compositions for fine line treatment
|
CA2838237C
(en)
|
2011-06-03 |
2020-05-26 |
Allergan, Inc. |
Dermal filler compositions including antioxidants
|
US20130096081A1
(en)
|
2011-06-03 |
2013-04-18 |
Allergan, Inc. |
Dermal filler compositions
|
US9393263B2
(en)
|
2011-06-03 |
2016-07-19 |
Allergan, Inc. |
Dermal filler compositions including antioxidants
|
US20130244943A1
(en)
|
2011-09-06 |
2013-09-19 |
Allergan, Inc. |
Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
|
US9662422B2
(en)
|
2011-09-06 |
2017-05-30 |
Allergan, Inc. |
Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
|
CN103957948B
(zh)
|
2011-10-11 |
2016-10-26 |
巴克斯特国际公司 |
止血组合物
|
CN103957949B
(zh)
|
2011-10-11 |
2017-07-18 |
巴克斯特国际公司 |
止血组合物
|
KR101975624B1
(ko)
|
2011-10-27 |
2019-05-07 |
백스터 인터내셔널 인코포레이티드 |
지혈 조성물
|
EP2822474B1
(en)
|
2012-03-06 |
2018-05-02 |
Ferrosan Medical Devices A/S |
Pressurized container containing haemostatic paste
|
US20230270916A1
(en)
*
|
2012-03-14 |
2023-08-31 |
MAM Holdings of West Florida, L.L.C. |
Collagen compositions and uses for biomaterial implants
|
AU2013275758B2
(en)
|
2012-06-12 |
2015-03-12 |
Ferrosan Medical Devices A/S |
Dry haemostatic composition
|
DE102012213496A1
(de)
|
2012-07-31 |
2014-05-15 |
Amedrix Gmbh |
Kit, dessen Verwendung und Verfahren zum Auffüllen von Bindegewebe der Haut
|
EA201591621A1
(ru)
|
2013-03-04 |
2015-12-30 |
ДЕРМЕЛЛ, ЭлЭлСи ди/би/эй ИТЕРНОДЖЕН, ЭлЭлСи |
Пригодная для инъекции способная к полимеризации in situ коллагеновая композиция
|
AU2014283170B2
(en)
|
2013-06-21 |
2017-11-02 |
Ferrosan Medical Devices A/S |
Vacuum expanded dry composition and syringe for retaining same
|
JP6489485B2
(ja)
|
2013-12-11 |
2019-03-27 |
フェロサン メディカル デバイシーズ エイ/エス |
押し出し増強因子を含んでいる乾燥組成物
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
ES2761558T3
(es)
|
2014-09-30 |
2020-05-20 |
Allergan Ind Sas |
Composiciones de hidrogel estables que incluyen aditivos
|
BR112017007466B1
(pt)
|
2014-10-13 |
2021-03-02 |
Ferrosan Medical Devices A/S |
método para preparar uma composição seca, método para reconstituir a composição seca, pasta, composição seca, recipiente, kit homeostático, e, uso de uma composição seca
|
US10653837B2
(en)
|
2014-12-24 |
2020-05-19 |
Ferrosan Medical Devices A/S |
Syringe for retaining and mixing first and second substances
|
WO2016128783A1
(en)
|
2015-02-09 |
2016-08-18 |
Allergan Industrie Sas |
Compositions and methods for improving skin appearance
|
FR3033697B1
(fr)
*
|
2015-03-17 |
2020-03-27 |
Universite Pierre Et Marie Curie (Paris 6) |
Suspensions de collagene injectables, leur procede de preparation et leurs utilisations, notamment pour la formation de matrices denses de collagene
|
KR20240042548A
(ko)
|
2015-06-03 |
2024-04-02 |
인타르시아 세라퓨틱스 인코포레이티드 |
임플란트 배치 및 제거 시스템들
|
US10918796B2
(en)
|
2015-07-03 |
2021-02-16 |
Ferrosan Medical Devices A/S |
Syringe for mixing two components and for retaining a vacuum in a storage condition
|
MA53353A
(fr)
|
2016-05-16 |
2021-06-09 |
Intarcia Therapeutics Inc |
Polypeptides sélectifs pour le récepteur du glucagon et méthodes pour leur utilisation
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
EP3565580B1
(en)
|
2017-01-03 |
2024-03-06 |
i2o Therapeutics, Inc. |
Continuous administration of exenatide and co-adminstration of acetaminophen, ethinylestradiol or levonorgestrel
|
US20210128778A1
(en)
|
2017-03-09 |
2021-05-06 |
Baxter International Inc. |
Solvent deposition system and methods
|
AU2019266529A1
(en)
|
2018-05-09 |
2020-12-03 |
Ethicon Inc. |
Method for preparing a haemostatic composition
|